{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T14:27:35Z","timestamp":1775485655565,"version":"3.50.1"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015518","name":"University of Nizwa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015518","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ejmech.2026.118653","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T17:14:03Z","timestamp":1770311643000},"page":"118653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design and synthesis of novel triazole-metronidazole boswellic acid hybrids for ovarian cancer targeting"],"prefix":"10.1016","volume":"307","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5103-9617","authenticated-orcid":false,"given":"Sadiq Noor","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6440-1523","authenticated-orcid":false,"given":"Samira","family":"Farhadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1563-225X","authenticated-orcid":false,"given":"Najeeb Ur","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8526-7799","authenticated-orcid":false,"given":"Sobia Ahsan","family":"Halim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8238-8074","authenticated-orcid":false,"given":"Issa S.","family":"Al-Amri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7851-6080","authenticated-orcid":false,"given":"Ajmal","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4740-5737","authenticated-orcid":false,"given":"Muhammad U.","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7911-290X","authenticated-orcid":false,"given":"Ren\u00e9","family":"Csuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3941-7164","authenticated-orcid":false,"given":"Satya Kumar","family":"Avula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0815-5942","authenticated-orcid":false,"given":"Ahmed","family":"Al-Harrasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.118653_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112669","article-title":"Anti-diabetic potential of \u03b2-boswellic acid and 11-keto-\u03b2-boswellic acid: mechanistic insights from computational and biochemical approaches","volume":"147","author":"Khan","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2026.118653_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bioorg.2018.04.020","article-title":"New \u03b1-glucosidase inhibitors from the resins of boswellia species with structure\u2013glucosidase activity and molecular docking studies","volume":"79","author":"Rehman","year":"2018","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118653_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-24229-y","article-title":"Comparative study of the cytotoxicity, apoptotic, and epigenetic effects of boswellic acid derivatives on breast cancer","volume":"12","author":"Jamshidi-Adegani","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.118653_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.139743","article-title":"Flurbiprofen clubbed schiff's base derivatives as potent anticancer agents: in vitro and in silico approach towards breast cancer","volume":"1321","author":"Alam","year":"2025","journal-title":"J. Mol. Struct."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118653_bib5","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1039\/B809437N","article-title":"Boswellic acids: a group of medicinally important compounds","volume":"26","author":"Shah","year":"2009","journal-title":"Nat. Prod. Rep."},{"issue":"8","key":"10.1016\/j.ejmech.2026.118653_bib6","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1080\/17460441.2021.1892640","article-title":"Boswellic acids: privileged structures to develop lead compounds for anticancer drug discovery","volume":"16","author":"Hussain","year":"2021","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.118653_bib7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jep.2015.12.039","article-title":"\u03b1-Pinene, linalool, and 1-octanol contribute to the topical anti-inflammatory and analgesic activities of frankincense by inhibiting COX-2","volume":"179","author":"Li","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2026.118653_bib8","first-page":"1","article-title":"Frankincense oil derived from Boswellia carteri induces tumor cell specific cytotoxicity","volume":"9","author":"Frank","year":"2009","journal-title":"BMC Compl. Alternative Med."},{"issue":"7","key":"10.1016\/j.ejmech.2026.118653_bib9","doi-asserted-by":"crossref","first-page":"6170","DOI":"10.1074\/jbc.M409477200","article-title":"Inhibition of I\u03baB kinase activity by acetyl-boswellic acids promotes apoptosis in androgen-independent PC-3 prostate cancer cells in vitro and in vivo","volume":"280","author":"Syrovets","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"1\u20104","key":"10.1016\/j.ejmech.2026.118653_bib10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/biof.5520130135","article-title":"Anti\u2010tumor and anti\u2010carcinogenic activities of triterpenoid, \u03b2\u2010boswellic acid","volume":"13","author":"Huang","year":"2000","journal-title":"Biofactors"},{"issue":"6-7","key":"10.1016\/j.ejmech.2026.118653_bib11","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.phymed.2007.11.019","article-title":"Boswellic acids: a leukotriene inhibitor also effective through topical application in inflammatory disorders","volume":"15","author":"Singh","year":"2008","journal-title":"Phytomedicine"},{"issue":"10","key":"10.1016\/j.ejmech.2026.118653_bib12","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1016\/j.bbagen.2013.06.039","article-title":"Acetyl-11-keto-beta-boswellic acid (AKBA) prevents human colonic adenocarcinoma growth through modulation of multiple signaling pathways","volume":"1830","author":"Yuan","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.ejmech.2026.118653_bib13","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/sj.bjc.6690419","article-title":"Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity","volume":"80","author":"Glaser","year":"1999","journal-title":"British journal of cancer"},{"issue":"9","key":"10.1016\/j.ejmech.2026.118653_bib14","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.fct.2011.04.007","article-title":"Antitumor properties of boswellic acid against ehrlich ascites cells bearing mouse","volume":"49","author":"Agrawal","year":"2011","journal-title":"Food Chem. Toxicol."},{"issue":"10","key":"10.1016\/j.ejmech.2026.118653_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026943","article-title":"Boswellic acid suppresses growth and metastasis of human pancreatic tumors in an orthotopic nude mouse model through modulation of multiple targets","volume":"6","author":"Park","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ejmech.2026.118653_bib16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-2000-9676","article-title":"Boswellic acids in the palliative therapy of children with progressive or relapsed brain tumors","volume":"212","author":"Janssen","year":"2000","journal-title":"Klin. P\u00e4diatr."},{"issue":"9","key":"10.1016\/j.ejmech.2026.118653_bib17","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1212\/WNL.56.9.1219","article-title":"Response of radiochemotherapy-associated cerebral edema to a phytotherapeutic agent, H15","volume":"56","author":"Streffer","year":"2001","journal-title":"Neurology"},{"issue":"16","key":"10.1016\/j.ejmech.2026.118653_bib18","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1002\/cncr.25945","article-title":"Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: a prospective, randomized, placebo\u2010controlled, double\u2010blind pilot trial","volume":"117","author":"Kirste","year":"2011","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ejmech.2026.118653_bib19","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1159\/000365884","article-title":"A case of metastatic bladder cancer in both lungs treated with Korean medicine therapy alone","volume":"7","author":"Lee","year":"2014","journal-title":"Case Rep. Oncol."},{"issue":"8","key":"10.1016\/j.ejmech.2026.118653_bib20","article-title":"Clinical evaluation of safety and efficacy of Boswellia-based cream for prevention of adjuvant radiotherapy skin damage in mammary carcinoma: a randomized placebo controlled trial","volume":"19","author":"Togni","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118653_bib21","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1080\/14786419.2019.1593165","article-title":"New derivatives of 11-keto-\u03b2-boswellic acid (KBA) induce apoptosis in breast and prostate cancers cells","volume":"35","author":"Bini Araba","year":"2021","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.ejmech.2026.118653_bib22","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejmech.2015.06.003","article-title":"11-Keto-boswellic acid derived amides and monodesmosidic saponins induce apoptosis in breast and cervical cancers cells","volume":"100","author":"Csuk","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"13","key":"10.1016\/j.ejmech.2026.118653_bib23","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1080\/14786419.2018.1564295","article-title":"Synthesis of new boswellic acid derivatives as potential antiproliferative agents","volume":"34","author":"Shamraiz","year":"2020","journal-title":"Nat. Prod. Res."},{"issue":"12","key":"10.1016\/j.ejmech.2026.118653_bib24","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1080\/14786419.2022.2116024","article-title":"Selective anti-cancer activity against melanoma cells using 3-O-acetyl-\u03b2-boswellic acid-loaded 3D-Printed scaffold","volume":"37","author":"Jamshidi-Adegani","year":"2023","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.ejmech.2026.118653_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110668","article-title":"Effect of boswellic acids on T cell proliferation and activation","volume":"122","author":"Meyiah","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejmech.2026.118653_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2025.106401","article-title":"Effect of boswellic acids on the expression of PD-1 and TIGIT immune checkpoints on activated human T cells","author":"Meyiah","year":"2025","journal-title":"Fitoterapia"},{"issue":"23","key":"10.1016\/j.ejmech.2026.118653_bib27","doi-asserted-by":"crossref","first-page":"8367","DOI":"10.3390\/molecules27238367","article-title":"Natural products as anticancer agents: current status and future perspectives","volume":"27","author":"Naeem","year":"2022","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.ejmech.2026.118653_bib28","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118653_bib29","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: a cancer journal for clinicians"},{"issue":"25","key":"10.1016\/j.ejmech.2026.118653_bib30","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"Journal of the American college of cardiology"},{"issue":"e146-e603","key":"10.1016\/j.ejmech.2026.118653_bib31","first-page":"1","article-title":"Heart disease and stroke statistics\u20132017 update","volume":"135","author":"Update","year":"2017","journal-title":"Circulation"},{"issue":"10177","key":"10.1016\/j.ejmech.2026.118653_bib32","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","article-title":"Epithelial ovarian cancer","volume":"393","author":"Lheureux","year":"2019","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ejmech.2026.118653_bib33","first-page":"284","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA: a cancer journal for clinicians"},{"issue":"3","key":"10.1016\/j.ejmech.2026.118653_bib34","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3390\/medicina59030544","article-title":"Ovarian cancer\u2014insights into platinum resistance and overcoming it","volume":"59","author":"Havasi","year":"2023","journal-title":"Medicina"},{"key":"10.1016\/j.ejmech.2026.118653_bib35","series-title":"Seminars in Oncology","article-title":"Genetic predisposition to endocrine tumors: diagnosis, surveillance and challenges in care","author":"Petr","year":"2016"},{"issue":"1","key":"10.1016\/j.ejmech.2026.118653_bib36","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1756-9966-31-14","article-title":"Therapeutic strategies in epithelial ovarian cancer","volume":"31","author":"Kim","year":"2012","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.ejmech.2026.118653_bib37","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrc4019","article-title":"Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer","volume":"15","author":"Bowtell","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.ejmech.2026.118653_bib38","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.annonc.2021.05.806","article-title":"Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set","volume":"32","author":"Klein","year":"2021","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118653_bib39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ygyno.2015.12.020","article-title":"Efficacy and safety of olaparib monotherapy in germline BRCA1\/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy","volume":"140","author":"Domchek","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"47","key":"10.1016\/j.ejmech.2026.118653_bib40","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","article-title":"Cisplatin: mode of cytotoxic action and molecular basis of resistance","volume":"22","author":"Siddik","year":"2003","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.ejmech.2026.118653_bib41","first-page":"501","article-title":"Keto- and acetyl-keto-boswellic acids inhibit proliferation and induce apoptosis in hep G2 cells via a caspase-8 dependent pathway","volume":"10","author":"Liu","year":"2002","journal-title":"Int. J. Mol. Med."},{"issue":"11","key":"10.1016\/j.ejmech.2026.118653_bib42","doi-asserted-by":"crossref","first-page":"9853","DOI":"10.1021\/acsomega.2c00203","article-title":"Synthesis of 3- -Acetyl-11-keto-\u03b2-boswellic acid (AKBA)-derived amides and their mitochondria-targeted antitumor activities","volume":"7","author":"Li","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2026.118653_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.135181","article-title":"Triazole-tethered boswellic acid derivatives against breast cancer: synthesis, in vitro, and studies","volume":"1282","author":"Avula","year":"2023","journal-title":"J. Mol. Struct."},{"issue":"23","key":"10.1016\/j.ejmech.2026.118653_bib44","first-page":"2505","article-title":"Pharmacological and cellular significance of triazole-surrogated compounds","volume":"23","author":"Verma","year":"2019","journal-title":"Curr. Org. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118653_bib45","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2174\/1389557520666201027160436","article-title":"Novel hybrid molecules based on triazole-\u03b2-lactam as potential biological agents","volume":"21","author":"Shiri","year":"2021","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118653_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.891484","article-title":"Synthesis methods of 1, 2, 3-\/1, 2, 4-triazoles: a review","volume":"10","author":"Dai","year":"2022","journal-title":"Front. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118653_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202100158","article-title":"1, 2, 3\u2010Triazole hybrids as anticancer agents: a review","volume":"355","author":"Alam","year":"2022","journal-title":"Arch. Pharmazie"},{"key":"10.1016\/j.ejmech.2026.118653_bib48","series-title":"Introduction: Click Chemistry","first-page":"6697","author":"Devaraj","year":"2021"},{"issue":"28","key":"10.1016\/j.ejmech.2026.118653_bib49","doi-asserted-by":"crossref","first-page":"12099","DOI":"10.1039\/C9NJ05685H","article-title":"Synthesis, characterization and in vitro anticancer activity of thiabendazole-derived 1, 2, 3-triazole derivatives","volume":"44","author":"El Bourakadi","year":"2020","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2026.118653_bib50","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bioorg.2018.08.008","article-title":"Synthesis of 1H-1, 2, 3-triazole derivatives as new \u03b1-glucosidase inhibitors and their molecular docking studies","volume":"81","author":"Avula","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118653_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103182","article-title":"Synthesis of novel (R)-4-fluorophenyl-1H-1, 2, 3-triazoles: a new class of \u03b1-glucosidase inhibitors","volume":"91","author":"Avula","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"13","key":"10.1016\/j.ejmech.2026.118653_bib52","doi-asserted-by":"crossref","first-page":"7638","DOI":"10.1021\/acs.chemrev.0c00920","article-title":"Cu (I)-catalyzed click chemistry in glycoscience and their diverse applications","volume":"121","author":"Agrahari","year":"2021","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2026.118653_bib53","series-title":"Acetyl-11-keto-\u03b2-boswellic Acid Inhibits Precancerous Breast Lesion MCF-10AT Cells via Regulation of LINC00707\/miR-206 that Reduces Estrogen receptor-\u03b1","first-page":"2301","author":"Jiang","year":"2020"},{"issue":"4","key":"10.1016\/j.ejmech.2026.118653_bib54","first-page":"501","article-title":"Keto-and acetyl-keto-boswellic acids inhibit proliferation and induce apoptosis in hep G2 cells via a caspase-8 dependent pathway","volume":"10","author":"Liu","year":"2002","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejmech.2026.118653_bib55","series-title":"Chemistry and Bioactivity of Boswellic Acids and Other Terpenoids of the Genus Boswellia","first-page":"127","article-title":"Frankincense in modern medicine","author":"Al\u2010Harrasi","year":"2018"},{"key":"10.1016\/j.ejmech.2026.118653_bib56","series-title":"Chemistry and Bioactivity of Boswellic Acids and Other Terpenoids of the Genus Boswellia","first-page":"111","article-title":"\u2014Biological activities of boswellia extract","author":"Al-Harrasi","year":"2019"},{"key":"10.1016\/j.ejmech.2026.118653_bib57","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.ejmech.2017.10.079","article-title":"Synthesis of new triterpenic monomers and dimers as potential antiproliferative agents and their molecular docking studies","volume":"143","author":"Saeed","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2026.118653_bib58","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1016\/j.ejmech.2010.05.036","article-title":"Synthesis of an antitumor active endoperoxide from 11-keto-\u03b2-boswellic acid","volume":"45","author":"Csuk","year":"2010","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118653_bib59","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ejphar.2011.07.024","article-title":"Potentiation of the antitumor effect of 11-keto-\u03b2-boswellic acid by its 3-\u03b1-hexanoyloxy derivative","volume":"668","author":"Chashoo","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118653_bib60","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.ejmech.2016.09.089","article-title":"Design and synthesis of novel 2-substituted 11-keto-boswellic acid heterocyclic derivatives as anti-prostate cancer agents with Pin1 inhibition ability","volume":"126","author":"Li","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2026.118653_bib61","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s00044-021-02723-8","article-title":"New synthetic 1 H-1, 2, 3-triazole derivatives of 3-O-acetyl-\u03b2-boswellic acid and 3-O-acetyl-11-keto-\u03b2-boswellic acid from Boswellia sacra inhibit carbonic anhydrase II in vitro","volume":"30","author":"Avula","year":"2021","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2026.118653_bib62","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.ejmech.2015.01.039","article-title":"Synthesis and antitumor activity of ring A modified 11-keto-\u03b2-boswellic acid derivatives","volume":"92","author":"Csuk","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"24","key":"10.1016\/j.ejmech.2026.118653_bib63","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1002\/ejoc.200300386","article-title":"An efficient method for the large\u2010scale preparation of 3\u2010O\u2010acetyl\u201011\u2010oxo\u2010\u03b2\u2010boswellic acid and other boswellic acids","volume":"2003","author":"Jauch","year":"2003","journal-title":"Eur. J. Org Chem."},{"issue":"13","key":"10.1016\/j.ejmech.2026.118653_bib64","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1038\/sj.onc.1209990","article-title":"Rapamycin induces feedback activation of akt signaling through an IGF-1R-dependent mechanism","volume":"26","author":"Wan","year":"2007","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.ejmech.2026.118653_bib65","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.3762\/bjoc.17.154","article-title":"Synthesis and antimicrobial activity of 1H-1, 2, 3-triazole and carboxylate analogues of metronidazole","volume":"17","author":"Avula","year":"2021","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.ejmech.2026.118653_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.135181","article-title":"Triazole\u2010tethered boswellic acid derivatives against breast cancer: synthesis, in vitro, and in\u2010silico studies","volume":"1282","author":"Avula","year":"2023","journal-title":"J. Mol. Struct."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118653_bib67","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/ph16020229","article-title":"Discovery of new boswellic acid hybrid 1 H-1, 2, 3-Triazoles for diabetic management: in vitro and in silico studies","volume":"16","author":"Rehman","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2026.118653_bib68","article-title":"Chemical computing group ULC","year":"2025","journal-title":"SSW."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342600098X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342600098X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T13:38:56Z","timestamp":1775482736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342600098X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":68,"alternative-id":["S022352342600098X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118653","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and synthesis of novel triazole-metronidazole boswellic acid hybrids for ovarian cancer targeting","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118653","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118653"}}